Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour

Depression and cardiovascular diseases are two of the world's major health problems. Escitalopram (ESC) is widely used because of its safety in relation to other drugs in that class; however, it can affect the cardiovascular system. The present study evaluated the cardiovascular parameters of d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Autonomic neuroscience 2024-12, Vol.256, p.103223, Article 103223
Hauptverfasser: Veríssimo, Luiz Fernando, Alves, Fernando Henrique Ferrari, Estrada, Viviane Batista, da Costa Marques, Leonardo Andre, Andrade, Karoliny Coelho, Bonancea, Amanda Monteiro, Okano, Natália Tavares, Corrêa, Fernando Morgan de Aguiar, Pelosi, Gislaine Garcia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 103223
container_title Autonomic neuroscience
container_volume 256
creator Veríssimo, Luiz Fernando
Alves, Fernando Henrique Ferrari
Estrada, Viviane Batista
da Costa Marques, Leonardo Andre
Andrade, Karoliny Coelho
Bonancea, Amanda Monteiro
Okano, Natália Tavares
Corrêa, Fernando Morgan de Aguiar
Pelosi, Gislaine Garcia
description Depression and cardiovascular diseases are two of the world's major health problems. Escitalopram (ESC) is widely used because of its safety in relation to other drugs in that class; however, it can affect the cardiovascular system. The present study evaluated the cardiovascular parameters of depressive-like male rats and the cardiovascular effects of ESC treatment on that condition. The EMS protocol consisted of separating the litter from the dam for 3 h over 13 days. Animals were anesthetized with tribromoethanol (250 mg/kg, intraperitoneally) and the catheters were inserted into the femoral and into the femoral vein. Depressive-like rats showed an increase in the pressor response to phenylephrine (Emax:depressive = 50.36 ± 2.997 mmHg; non-depressive = 39.51 ± 3.328 mmHg; p 
doi_str_mv 10.1016/j.autneu.2024.103223
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_3140893182</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1566070224000778</els_id><sourcerecordid>3140893182</sourcerecordid><originalsourceid>FETCH-LOGICAL-e196t-dde801030c8ae268f8978d22b0062f22aeabff60630112011f5e6323c6cbbd1b3</originalsourceid><addsrcrecordid>eNo1kcuKGzEQRUVIiD2PPwhBy2zaKUltWb0JBDOPwMBsJmtR3SoxcvoVSe0wfx8ZexaiRHEoqu5h7IuAjQChvx82uOSRlo0EWZeWklJ9YGthdrLa1ab-WP5brSvYgVyxq5QOAGCg0Z_ZSjVa6KY2a7bsMbowHTF1S4-Rk_fU5cQnzwlj_8YHzBRH7HmiGSPmMI0cR8cpdSFjP80RB54jYR5ozDyMvECJ_wv5lTuaI6UUjlT14Q_xll7xGKYl3rBPHvtEt5d6zX7f373sH6un54df-59PFYlG58o5MlAug84gSW28aXbGSdkCaOmlRMLWew1agRCyPL8lraTqdNe2TrTqmn07z53j9HehlO0QUkd9jyNNS7JK1GAaJYws6NcLurQDOTvHMGB8s-9RFeDHGaCy8DFQtCUBGjtyIZbIrJuCFWBPbuzBnt3Ykxt7dqP-A2t-hOY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3140893182</pqid></control><display><type>article</type><title>Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Veríssimo, Luiz Fernando ; Alves, Fernando Henrique Ferrari ; Estrada, Viviane Batista ; da Costa Marques, Leonardo Andre ; Andrade, Karoliny Coelho ; Bonancea, Amanda Monteiro ; Okano, Natália Tavares ; Corrêa, Fernando Morgan de Aguiar ; Pelosi, Gislaine Garcia</creator><creatorcontrib>Veríssimo, Luiz Fernando ; Alves, Fernando Henrique Ferrari ; Estrada, Viviane Batista ; da Costa Marques, Leonardo Andre ; Andrade, Karoliny Coelho ; Bonancea, Amanda Monteiro ; Okano, Natália Tavares ; Corrêa, Fernando Morgan de Aguiar ; Pelosi, Gislaine Garcia</creatorcontrib><description>Depression and cardiovascular diseases are two of the world's major health problems. Escitalopram (ESC) is widely used because of its safety in relation to other drugs in that class; however, it can affect the cardiovascular system. The present study evaluated the cardiovascular parameters of depressive-like male rats and the cardiovascular effects of ESC treatment on that condition. The EMS protocol consisted of separating the litter from the dam for 3 h over 13 days. Animals were anesthetized with tribromoethanol (250 mg/kg, intraperitoneally) and the catheters were inserted into the femoral and into the femoral vein. Depressive-like rats showed an increase in the pressor response to phenylephrine (Emax:depressive = 50.36 ± 2.997 mmHg; non-depressive = 39.51 ± 3.328 mmHg; p &lt; 0.05) and a reduction in the EC50 (depressive = 0.6203 ± 0.03005 μg/kg; non-depressive = 0.7320 ± 0.03519 μg/kg; p &lt; 0.05) with no change in the other cardiovascular parameters. After treatment with ESC, a reduction of intrinsic heart rate was observed in the depressive-like rats (control: 342 ± 6 bpm; ESC: 316 ± 5 bpm; p &lt; 0.05). In addition, ESC treatment increased the bradycardic (control: −97.81 ± 8.3 bpm; ESC: −137.1 ± 12.31 bpm; p = 0.0236; t = 2.502) during the baroreflex response, caused by an increase in cardiac parasympathetic modulation in the heart, in depressive-like rats (p &lt; 0.001). The findings suggest that depressive-like rats showed cardiovascular changes, and that ESC treatment was able to reverse these changes, suggesting that ESC has a good safety profile for depressive patients with cardiovascular disease due to increased parasympathetic modulation. •Early maternal separation induces an increase in cardiovascular response.•Escitalopram treatment reverts the changes caused by maternal separation.•Escitalopram treatment increases parasympathetic modulation.•Escitalopram mechanism facilitates parasympathetic modulation.•Cardiovascular consequences from early maternal separation can be alleviated by escitalopram treatment.</description><identifier>ISSN: 1566-0702</identifier><identifier>ISSN: 1872-7484</identifier><identifier>EISSN: 1872-7484</identifier><identifier>DOI: 10.1016/j.autneu.2024.103223</identifier><identifier>PMID: 39616948</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Antidepressive Agents, Second-Generation - pharmacology ; Baroreflex - drug effects ; Baroreflex - physiology ; Blood Pressure - drug effects ; Blood Pressure - physiology ; Cardiovascular safety ; Citalopram - pharmacology ; Depression ; Depression - drug therapy ; Depression - physiopathology ; Depressive-like behaviour ; Disease Models, Animal ; Escitalopram - pharmacology ; Female ; Heart Rate - drug effects ; Male ; Maternal Deprivation ; Phenylephrine - pharmacology ; Rats ; Rats, Wistar ; Selective serotonin reuptake inhibitor</subject><ispartof>Autonomic neuroscience, 2024-12, Vol.256, p.103223, Article 103223</ispartof><rights>2024 Elsevier B.V.</rights><rights>Copyright © 2024 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.autneu.2024.103223$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39616948$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Veríssimo, Luiz Fernando</creatorcontrib><creatorcontrib>Alves, Fernando Henrique Ferrari</creatorcontrib><creatorcontrib>Estrada, Viviane Batista</creatorcontrib><creatorcontrib>da Costa Marques, Leonardo Andre</creatorcontrib><creatorcontrib>Andrade, Karoliny Coelho</creatorcontrib><creatorcontrib>Bonancea, Amanda Monteiro</creatorcontrib><creatorcontrib>Okano, Natália Tavares</creatorcontrib><creatorcontrib>Corrêa, Fernando Morgan de Aguiar</creatorcontrib><creatorcontrib>Pelosi, Gislaine Garcia</creatorcontrib><title>Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour</title><title>Autonomic neuroscience</title><addtitle>Auton Neurosci</addtitle><description>Depression and cardiovascular diseases are two of the world's major health problems. Escitalopram (ESC) is widely used because of its safety in relation to other drugs in that class; however, it can affect the cardiovascular system. The present study evaluated the cardiovascular parameters of depressive-like male rats and the cardiovascular effects of ESC treatment on that condition. The EMS protocol consisted of separating the litter from the dam for 3 h over 13 days. Animals were anesthetized with tribromoethanol (250 mg/kg, intraperitoneally) and the catheters were inserted into the femoral and into the femoral vein. Depressive-like rats showed an increase in the pressor response to phenylephrine (Emax:depressive = 50.36 ± 2.997 mmHg; non-depressive = 39.51 ± 3.328 mmHg; p &lt; 0.05) and a reduction in the EC50 (depressive = 0.6203 ± 0.03005 μg/kg; non-depressive = 0.7320 ± 0.03519 μg/kg; p &lt; 0.05) with no change in the other cardiovascular parameters. After treatment with ESC, a reduction of intrinsic heart rate was observed in the depressive-like rats (control: 342 ± 6 bpm; ESC: 316 ± 5 bpm; p &lt; 0.05). In addition, ESC treatment increased the bradycardic (control: −97.81 ± 8.3 bpm; ESC: −137.1 ± 12.31 bpm; p = 0.0236; t = 2.502) during the baroreflex response, caused by an increase in cardiac parasympathetic modulation in the heart, in depressive-like rats (p &lt; 0.001). The findings suggest that depressive-like rats showed cardiovascular changes, and that ESC treatment was able to reverse these changes, suggesting that ESC has a good safety profile for depressive patients with cardiovascular disease due to increased parasympathetic modulation. •Early maternal separation induces an increase in cardiovascular response.•Escitalopram treatment reverts the changes caused by maternal separation.•Escitalopram treatment increases parasympathetic modulation.•Escitalopram mechanism facilitates parasympathetic modulation.•Cardiovascular consequences from early maternal separation can be alleviated by escitalopram treatment.</description><subject>Animals</subject><subject>Antidepressive Agents, Second-Generation - pharmacology</subject><subject>Baroreflex - drug effects</subject><subject>Baroreflex - physiology</subject><subject>Blood Pressure - drug effects</subject><subject>Blood Pressure - physiology</subject><subject>Cardiovascular safety</subject><subject>Citalopram - pharmacology</subject><subject>Depression</subject><subject>Depression - drug therapy</subject><subject>Depression - physiopathology</subject><subject>Depressive-like behaviour</subject><subject>Disease Models, Animal</subject><subject>Escitalopram - pharmacology</subject><subject>Female</subject><subject>Heart Rate - drug effects</subject><subject>Male</subject><subject>Maternal Deprivation</subject><subject>Phenylephrine - pharmacology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Selective serotonin reuptake inhibitor</subject><issn>1566-0702</issn><issn>1872-7484</issn><issn>1872-7484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kcuKGzEQRUVIiD2PPwhBy2zaKUltWb0JBDOPwMBsJmtR3SoxcvoVSe0wfx8ZexaiRHEoqu5h7IuAjQChvx82uOSRlo0EWZeWklJ9YGthdrLa1ab-WP5brSvYgVyxq5QOAGCg0Z_ZSjVa6KY2a7bsMbowHTF1S4-Rk_fU5cQnzwlj_8YHzBRH7HmiGSPmMI0cR8cpdSFjP80RB54jYR5ozDyMvECJ_wv5lTuaI6UUjlT14Q_xll7xGKYl3rBPHvtEt5d6zX7f373sH6un54df-59PFYlG58o5MlAug84gSW28aXbGSdkCaOmlRMLWew1agRCyPL8lraTqdNe2TrTqmn07z53j9HehlO0QUkd9jyNNS7JK1GAaJYws6NcLurQDOTvHMGB8s-9RFeDHGaCy8DFQtCUBGjtyIZbIrJuCFWBPbuzBnt3Ykxt7dqP-A2t-hOY</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Veríssimo, Luiz Fernando</creator><creator>Alves, Fernando Henrique Ferrari</creator><creator>Estrada, Viviane Batista</creator><creator>da Costa Marques, Leonardo Andre</creator><creator>Andrade, Karoliny Coelho</creator><creator>Bonancea, Amanda Monteiro</creator><creator>Okano, Natália Tavares</creator><creator>Corrêa, Fernando Morgan de Aguiar</creator><creator>Pelosi, Gislaine Garcia</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour</title><author>Veríssimo, Luiz Fernando ; Alves, Fernando Henrique Ferrari ; Estrada, Viviane Batista ; da Costa Marques, Leonardo Andre ; Andrade, Karoliny Coelho ; Bonancea, Amanda Monteiro ; Okano, Natália Tavares ; Corrêa, Fernando Morgan de Aguiar ; Pelosi, Gislaine Garcia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e196t-dde801030c8ae268f8978d22b0062f22aeabff60630112011f5e6323c6cbbd1b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Animals</topic><topic>Antidepressive Agents, Second-Generation - pharmacology</topic><topic>Baroreflex - drug effects</topic><topic>Baroreflex - physiology</topic><topic>Blood Pressure - drug effects</topic><topic>Blood Pressure - physiology</topic><topic>Cardiovascular safety</topic><topic>Citalopram - pharmacology</topic><topic>Depression</topic><topic>Depression - drug therapy</topic><topic>Depression - physiopathology</topic><topic>Depressive-like behaviour</topic><topic>Disease Models, Animal</topic><topic>Escitalopram - pharmacology</topic><topic>Female</topic><topic>Heart Rate - drug effects</topic><topic>Male</topic><topic>Maternal Deprivation</topic><topic>Phenylephrine - pharmacology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Selective serotonin reuptake inhibitor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Veríssimo, Luiz Fernando</creatorcontrib><creatorcontrib>Alves, Fernando Henrique Ferrari</creatorcontrib><creatorcontrib>Estrada, Viviane Batista</creatorcontrib><creatorcontrib>da Costa Marques, Leonardo Andre</creatorcontrib><creatorcontrib>Andrade, Karoliny Coelho</creatorcontrib><creatorcontrib>Bonancea, Amanda Monteiro</creatorcontrib><creatorcontrib>Okano, Natália Tavares</creatorcontrib><creatorcontrib>Corrêa, Fernando Morgan de Aguiar</creatorcontrib><creatorcontrib>Pelosi, Gislaine Garcia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Autonomic neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Veríssimo, Luiz Fernando</au><au>Alves, Fernando Henrique Ferrari</au><au>Estrada, Viviane Batista</au><au>da Costa Marques, Leonardo Andre</au><au>Andrade, Karoliny Coelho</au><au>Bonancea, Amanda Monteiro</au><au>Okano, Natália Tavares</au><au>Corrêa, Fernando Morgan de Aguiar</au><au>Pelosi, Gislaine Garcia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour</atitle><jtitle>Autonomic neuroscience</jtitle><addtitle>Auton Neurosci</addtitle><date>2024-12</date><risdate>2024</risdate><volume>256</volume><spage>103223</spage><pages>103223-</pages><artnum>103223</artnum><issn>1566-0702</issn><issn>1872-7484</issn><eissn>1872-7484</eissn><abstract>Depression and cardiovascular diseases are two of the world's major health problems. Escitalopram (ESC) is widely used because of its safety in relation to other drugs in that class; however, it can affect the cardiovascular system. The present study evaluated the cardiovascular parameters of depressive-like male rats and the cardiovascular effects of ESC treatment on that condition. The EMS protocol consisted of separating the litter from the dam for 3 h over 13 days. Animals were anesthetized with tribromoethanol (250 mg/kg, intraperitoneally) and the catheters were inserted into the femoral and into the femoral vein. Depressive-like rats showed an increase in the pressor response to phenylephrine (Emax:depressive = 50.36 ± 2.997 mmHg; non-depressive = 39.51 ± 3.328 mmHg; p &lt; 0.05) and a reduction in the EC50 (depressive = 0.6203 ± 0.03005 μg/kg; non-depressive = 0.7320 ± 0.03519 μg/kg; p &lt; 0.05) with no change in the other cardiovascular parameters. After treatment with ESC, a reduction of intrinsic heart rate was observed in the depressive-like rats (control: 342 ± 6 bpm; ESC: 316 ± 5 bpm; p &lt; 0.05). In addition, ESC treatment increased the bradycardic (control: −97.81 ± 8.3 bpm; ESC: −137.1 ± 12.31 bpm; p = 0.0236; t = 2.502) during the baroreflex response, caused by an increase in cardiac parasympathetic modulation in the heart, in depressive-like rats (p &lt; 0.001). The findings suggest that depressive-like rats showed cardiovascular changes, and that ESC treatment was able to reverse these changes, suggesting that ESC has a good safety profile for depressive patients with cardiovascular disease due to increased parasympathetic modulation. •Early maternal separation induces an increase in cardiovascular response.•Escitalopram treatment reverts the changes caused by maternal separation.•Escitalopram treatment increases parasympathetic modulation.•Escitalopram mechanism facilitates parasympathetic modulation.•Cardiovascular consequences from early maternal separation can be alleviated by escitalopram treatment.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>39616948</pmid><doi>10.1016/j.autneu.2024.103223</doi></addata></record>
fulltext fulltext
identifier ISSN: 1566-0702
ispartof Autonomic neuroscience, 2024-12, Vol.256, p.103223, Article 103223
issn 1566-0702
1872-7484
1872-7484
language eng
recordid cdi_proquest_miscellaneous_3140893182
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Antidepressive Agents, Second-Generation - pharmacology
Baroreflex - drug effects
Baroreflex - physiology
Blood Pressure - drug effects
Blood Pressure - physiology
Cardiovascular safety
Citalopram - pharmacology
Depression
Depression - drug therapy
Depression - physiopathology
Depressive-like behaviour
Disease Models, Animal
Escitalopram - pharmacology
Female
Heart Rate - drug effects
Male
Maternal Deprivation
Phenylephrine - pharmacology
Rats
Rats, Wistar
Selective serotonin reuptake inhibitor
title Cardiovascular effects of early maternal separation and escitalopram treatment in rats with depressive-like behaviour
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T12%3A47%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cardiovascular%20effects%20of%20early%20maternal%20separation%20and%20escitalopram%20treatment%20in%20rats%20with%20depressive-like%20behaviour&rft.jtitle=Autonomic%20neuroscience&rft.au=Ver%C3%ADssimo,%20Luiz%20Fernando&rft.date=2024-12&rft.volume=256&rft.spage=103223&rft.pages=103223-&rft.artnum=103223&rft.issn=1566-0702&rft.eissn=1872-7484&rft_id=info:doi/10.1016/j.autneu.2024.103223&rft_dat=%3Cproquest_pubme%3E3140893182%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3140893182&rft_id=info:pmid/39616948&rft_els_id=S1566070224000778&rfr_iscdi=true